Founded in 1990 and fully owned by PharmaMar, GENOMICA develops, manufactures, and sells diagnostic kits using their CLART® platform, which allows for the simultaneous detection of multiple targets in a single test. They also offer services in genetic identification, forensic genetics, and molecular development, with a focus on improving current methods of diagnosis and identification using reliable and automatic tools.